Deregulation in immune responses has been associated with disturbances in IGF1 and IGF1R in typical neonatal pulmonary diseases, such as respiratory distress syndrome and bronchopulmonary dysplasia [8], [9]. This evidence concerns the gene IGF1R and bronchopulmonary dysplasia.